Answers are grounded in this paper and cite their sources.
The present report describes in detail the synthesis and characterisation of the protected Calcitonin M decapeptide 1–10, , a key intermediate in the synthesis of Calcitonin M. I. was obtained from the openchain precursor Boc‐Cys (Trt)‐Gly‐Asn‐Leu‐Ser (But)‐Thr (But)‐Cys (Trt)‐Met‐Leu‐Gly‐OH (II) by oxidation with iodine in a yield of 70%, after purification by counter‐current distribution. II was prepared by fragment coupling of the sequences 1–4 and 5–10. The free calcitonin M (1–10)‐decapeptide, obtained from I by removal of the protecting groups by acidolysis, has no hypocalcaemic activity and does not inhibit specific binding of calcitonin M to its antibodies in rabbit serum.
No takes yet. Share an insight, caveat, or question.
Kamber et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: